Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
15don MSN
Forget Ozempic: This high‑flying device maker can thrive no matter which weight loss drug wins
Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results